17th October 2022
Bridge Therapeutics Wins Most Fundable Company by Pepperdine Graziadio Business School
Birmingham, AL, Oct. 17, 2022: Bridge Therapeutics is delighted to announce that it achieved a Bronze Award on the Pepperdine Graziadio Business School’s fifth annual Most Fundable Companies® List. Bridge Therapeutics competed against over 4,000 of early-stage US companies to be named one of 16 finalists. The Most Fundable Companies initiative aims to educate founders on the investor diligence process and recognize exceptional entrepreneurs who are solving today’s problems with inventive solutions and are also seeking investment capital to fuel their company’s growth. Watch our event video.
“We’re a 4-year-old start-up with big ambitions, and recognition as a Most Fundable Company of 2022 positions us well for our next capital raise and brings us one step closer to achieving market leadership,” said Bridge’s President, Tim Peara. “The Most Fundable Companies initiative was one of the most intensive diligence processes we’ve ever participated in, and we’re thrilled to have arrived on top through data-driven analysis. Entrepreneurial business ingenuity is the life blood of the US economy, and we’re excited that the Pepperdine Graziadio Business School is giving entrepreneurs a platform to showcase their business and set them up for success with investors.”
Bridge is developing safe, strong alternatives to opioids for pain and major improvements in addiction therapies. As a business, Bridge is extremely low risk since it combines proven ingredients with a best-in-class delivery system while attacking multi-billion-dollar markets and building barriers to entry with each successive therapy.
As a winner on the Most Fundable Companies List, Bridge Therapeutics will be profiled on Entrepreneur.com and will be featured in the December print issue of Entrepreneur magazine. For a complete list of the winners, visit www.pepperdine.edu/mfc-list, where you can also vote for Bridge Therapeutics through October 24.
About Pepperdine Most Fundable Companies
The Most Fundable Companies List is an annual program hosted by the Pepperdine Graziadio Business School aimed to promote startup business development by providing pathways for startup funding and inspiring entrepreneurial spirit across the nation. More than 4,000 companies across all 50 states applied for the 2022 program. The Pepperdine Graziadio Business School’s Most Fundable Companies Showcase presented by the Singleton Foundation for Financial Literacy and Entrepreneurship took place on October 13, 2022 at Pepperdine University’s Villa Graziadio Executive Center.
The Most Fundable Companies program was launched by the Pepperdine Graziadio Business School in 2018 as a free resource to help entrepreneurs assess their readiness for private investment. The initiative involves a multi-phase assessment that evaluates several company variables, including financial projections, market opportunity, intellectual property, and the strength of the management team, all of which are used to generate objective and customized feedback and scoring to improve readiness for funding. Pepperdine Graziadio Business School’s Most Fundable Companies is powered by The Venture Alliance.
About Bridge Therapeutics
Bridge Therapeutics, Inc (Addiction & Pain Therapies | Bridge Therapeutics) is a development-stage pharmaceutical company pursuing FDA approval of BT‑219 for Opioid Use Disorder (OUD), and BT-205 for the treatment of chronic pain in opioid-experienced patients. The Company’s mission is to improve the healthcare of millions of patients through safer and more effective therapies for OUD and chronic pain.
Director of Business Development
Disclaimers: The Pepperdine Most Fundable Companies list does not represent an offer to sell securities. It does not constitute investment advice, nor is it an endorsement of any particular product or service. Pepperdine University is not a broker-dealer and does not perform services provided by a broker-dealer, including but not limited to any financial or investment advising.